IDYA Ideaya Biosciences, Inc.

$31.27 +0.03%

Healthcare · Pharmaceutical Preparations

Ideaya Biosciences, Inc. (IDYA) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $2.7 billion. Shares last traded at $31.27, 27.8% below their 52-week high. Over the past year the stock is up 42.5%. Net profit margin is -52.0%, below the peer median of -0.1%. Revenue grew 3024.4% year over year.

Market Cap

$2.7B

Shares Out

87.9M

EPS (TTM)

$-3.96

P/E Ratio

—

P/S Ratio

12.56

P/B Ratio

2.93

Dividend / Share

—

Dividend Yield

—

52-Week High

$43.28

52-Week Low

$20.62

Volume

66,362

Avg Vol (3m)

64,984.079

Performance

+8.41%

+10.32%

-4.04%

-7.53%

YTD

-7.69%

+42.50%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

58.04

SMA (50)

$29.82

SMA (200)

$31.24

Price vs SMA50

+4.84%

Price vs SMA200

+0.07%

ATR (14)

$1.98

Financials

Revenue

$219M

Net Income

$-114M

Gross Margin

—

Operating Margin

-72.8%

Net Margin

-52.0%

Return on Equity

-12.1%

Return on Assets

-11.0%

Current Ratio

10.74

Debt / Equity

0.10

Revenue Growth (YoY)

+3024.4%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-1.11	2026-05-05
FY 2025	$-1.28	2026-02-17
Q3 2025	$-0.34	2025-11-04
Q2 2025	$-1.69	2025-08-05
Q1 2026	$-0.82	2026-05-05
FY 2025	$-3.36	2026-02-17

Full earnings history →

Pharmaceutical Preparations peers

IDYA vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

12.56 / 3.54 med

+255% premium

Net margin vs peers

-52.0% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.